ABL103

DRUG2 trials

Sponsors

ABL Bio, Inc.

Conditions

Advanced Solid TumorSolid Tumors

Phase 1

A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors

RecruitingNCT06126666

ABL Bio, Inc.Advanced Solid Tumor

Start: 2023-11-07End: 2027-11-15Target: 96Updated: 2025-10-01

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

RecruitingNCT07158918

ABL Bio, Inc.Solid Tumors

Start: 2025-08-06End: 2027-12-02Target: 65Updated: 2025-09-08